Terms ending in 2041
Every in-force patent on Lifeedit, Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,981,916 | RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use In force · Medium confidence | LifeEDIT Therapeutics, Inc. | In force | Medium confidence | |
| US 12,252,706 | RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use In force · Low confidence | Life Edit Therapeutics, Inc. | In force | Low confidence | |
| US 11,859,181 | RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use In force · High confidence | Lifeedit Therapeutics, Inc. | In force | High confidence | |
| US 11,981,940 | DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use In force · Medium confidence | Life Edit Therapeutics, Inc. | In force | Medium confidence | |
| US 12,188,061 | Nucleic Acid Molecules Encoding DNA Modifying Enzymes and Active Fragments and Variants Thereof and Compositions Comprising the Same In force · Medium confidence | Life Edit Therapeutics, Inc. | In force | Medium confidence | |
| US 12,188,062 | DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use In force · Medium confidence | Life Edit Therapeutics, Inc. | In force | Medium confidence | |
| US 12,252,718 | DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use In force · Medium confidence | Life Edit Therapeutics, Inc. | In force | Medium confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.